Insider · CIK 0001378690

Schroeder Theodore R

Reports to the SEC for 8 companies · FLORHAM PARK, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001378690

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-19	PHATPhathom Pharmaceuticals, Inc.A Award	Director	AAward	+24.1K sh	—	—	45,122
2026-01-07	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−450 sh	—	—	0
2026-01-07	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−550 sh	—	—	0
2026-01-07	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−550 sh	—	—	0
2026-01-07	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−550 sh	—	—	0
2026-01-07	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−875 sh	—	—	0
2026-01-07	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−875 sh	—	—	0
2026-01-07	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,400 sh	—	—	0
2026-01-07	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,125 sh	—	—	0
2026-01-07	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,125 sh	—	—	0
2026-01-07	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20.5K sh	—	—	0
2026-01-07	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−11.1K sh	—	—	0
2025-06-18	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+11.1K sh	—	—	11,100
2025-04-16	PHATPhathom Pharmaceuticals, Inc.A Award	Director	AAward	+21K sh	—	—	21,000
2025-04-16	PHATPhathom Pharmaceuticals, Inc. · Common Stock (Right to Buy)A Award	Director	AAward	+35K sh	—	—	35,000
2024-12-17	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+20.5K sh	—	—	20,500
2024-07-18	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+2,125 sh	—	—	2,125
2023-06-22	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+42.5K sh	—	—	42,500
2023-01-29	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−431 sh	$1.50	−$646.5	11,989
2023-01-06	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−11 sh	$1.30	−$14.3	12,420
2022-12-31	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−5 sh	$1.89	−$9.45	12,431
2022-12-06	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−9 sh	$2.02	−$18.18	12,436
2022-11-30	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−5 sh	$2.25	−$11.25	12,445
2022-11-06	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−10 sh	$2.24	−$22.392	12,450
2022-10-31	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−5 sh	$2.54	−$12.7	12,460
2022-10-06	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−9 sh	$2.72	−$24.48	12,465
2022-09-30	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−5 sh	$2.08	−$10.4	12,474
2022-09-06	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−225 sh	$0.16	−$35.235	311,977
2022-08-31	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−107 sh	$0.16	−$17.612	312,202
2022-08-11	Nabriva Therapeutics plcShare OptionsM Exercise/Conversion	Director	MExercise/Conversion	−240K sh	—	—	0
2022-08-11	Nabriva Therapeutics plcRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−120K sh	—	—	0
2022-08-11	Nabriva Therapeutics plcStock Appreciation RightM Exercise/Conversion	Director	MExercise/Conversion	+240K sh	—	—	239,800
2022-08-11	Nabriva Therapeutics plcPhantom SharesM Exercise/Conversion	Director	MExercise/Conversion	+120K sh	—	—	119,900
2022-08-06	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−225 sh	$0.18	−$41.558	312,309
2022-07-31	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−107 sh	$0.18	−$19.153	312,534
2022-07-06	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−225 sh	$0.18	−$40.995	312,641
2022-06-30	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−107 sh	$0.18	−$19.474	312,866
2022-06-22	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+28K sh	—	—	28,000
2022-06-21	OTONOMY, INC.Stock Option (right to buy)A Award	Director	AAward	+27.5K sh	—	—	27,500
2022-06-06	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−225 sh	$0.20	−$45	312,973
2022-05-31	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−107 sh	$0.21	−$22.106	313,198
2022-05-06	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−225 sh	$0.26	−$58.5	313,305
2022-04-30	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−107 sh	$0.31	−$33.17	313,530
2022-04-06	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−219 sh	$0.41	−$89.79	313,637
2022-03-31	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−104 sh	$0.42	−$43.68	313,856
2022-03-06	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−263 sh	$0.43	−$113.09	313,960
2022-02-28	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−125 sh	$0.45	−$56.25	314,223
2022-02-06	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−263 sh	$0.48	−$126.24	314,348
2022-01-31	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−125 sh	$0.48	−$60	314,611
2022-01-29	Nabriva Therapeutics plcF Tax Payment	Director	FTax Payment	−10.8K sh	$0.45	−$4,844.7	314,736

Recent filings

Accepted (ET)
May 214
Schroeder Theodore R0001193125-26-234563
SEC(opens sec.gov)
Jan 74
Schroeder Theodore R0001378690-26-000003
SEC(opens sec.gov)
Jun 184
Schroeder Theodore R0001610618-25-000067
SEC(opens sec.gov)
Apr 164
Schroeder Theodore R0000950170-25-054886
SEC(opens sec.gov)
Dec 194
Schroeder Theodore R0001610618-24-000154
SEC(opens sec.gov)
Jul 194
Schroeder Theodore R0001610618-24-000098
SEC(opens sec.gov)
Jun 234
Schroeder Theodore R0001610618-23-000069
SEC(opens sec.gov)
Jan 314
Schroeder Theodore R0001104659-23-008854
SEC(opens sec.gov)
Jan 104
Schroeder Theodore R0001104659-23-002821
SEC(opens sec.gov)

Companies

Address

C/O PHATHOM PHARMACEUTICALS, INC. 100 CAMPUS DRIVE, SUITE 102

FLORHAM PARK, NJ, 07932